- Alvogen Korea holds the marketing authorization for Seroquel® and Seroquel XR® following its exclusive domestic distribution and marketing rights, granted by Luye Pharma.
- With this partnership, Alvogen Korea expects to further enhance their position in the CNS medication field, achieving steady growth in the market.